New Technologies to de termine Carotid 
Plaque Vulnerability: A Pilot Study to 
Assess Contrast -Enhanced Ultrasound 
(CEUS) and Shear Wave Elastography 
(SWE) in Patients with Significant Carotid 
Plaques  
 
[STUDY_ID_REMOVED]  
 
 
8/24/2018  
 
  Page 3 of 13 
 Patient  selection:  We will prospectively  recruit  80 patients  for this study  from  patients  being  seen in the Gonda  
Vascular  Center.  Patients  with known  plaques  will be screened  before  a scheduled  appointment.  Alternatively,  
patients  undergoing  an ultrasound  examination  in the Gonda  Vascular  Center  may also be identified  for 
recruitment.   Patients  who are will be undergoing  a carotid  endarterectomy  will be approached  for recruitment.  
Additionally,  patients  are going  to be scanned  and have  a known  moderate  (50-69%)  stenosis  or a newly  
discovered  moderate  stenosis  will be approached  for recruitment.  We will prospectively  enroll  20 patients  that 
are under going  carotid  endarterectomy  and 60 cardiovascular  high-risk patients  with moderate  or severe  (50% -
99% diameter)  stenosis  carotid  plaques  from  the Gonda  Vascular  Center  practice  for evaluation  with SWE  and 
CEUS.  The main  indications  of high-risk patients  are multiple  cardiovascular  risk factors,  carotid  bruit,  known  
atherosclerotic  disease  in coronary  (>50%  stenosis  confirmed  by angiography),  or peripheral  artery  disease  
(according  to medical  history).  
Ultrasound  protocol:  A standard  carotid  US examination  using  Duplex  imaging  will performed  using  a 9 MHz  
linear  array  transducer  to obtain  longitudinal  and transverse  images.  All ultrasound  measurements  will be made  
by a trained  registered  vascular  technologist.  Severity  of stenosis  of the plaque  will be measu red based  on 
established  protocol  and guidelines  outlined  in [44].  SWE  will be performed  with the GE Logiq  E9 scanner  
acquiring  images  of each plaque  in the longitudinal  and transverse  imaging  planes.  In each plane  10 
measurements  will be made  and the in-phase/quadrature  (IQ) data will be saved  for further  analysis.  The plaque  
area in the imaging  plane  will be user-defined  to extract  the wave  velocity  values  for a ROI analysis.  A mean  
and median  of repeated  measurements  will be calculated.  Additionally,  the calculated  wave  motion  will be 
analyzed  further  for characterization  of the plaque.   
CEUS  will be performed  using  low mechanical  index  (0.17 -0.20)  imaging  during  ultrasound  contrast  agent  
intravenous  infusion.  The ultrasound  contrast  agent  that will be used is Lumason  (Bracco  Diagnostics,  Inc). Real-
time cine-loop including  longitudinal  and transverse  images  obtained  at least 3 seconds  before  and 5 minutes  
after the appearance  of the contrast  effect  in the lumen  of the carotid  artery  will be acquired  and digitally  stored  
for offline  analysis.  IPN will be visually  graded  according  to microbubble  location  and kinetics:  G0: no visible  
microbubbles  within  the plaque;  G1: moderate  microbubbles  confined  to the shoulder  and/or  adventitial  side of 
the plaque;  or G2: extensive  microbubbles  throughout  the plaque,  with clear  visible  appearance  of bubble  
moving  into the plaque  core.  We will also use a 3D ultrasound  transducer  to evaluate  the feasibility  of using  US 
images  with contrast  to assess  the residual  diameter  of the diseased  vessel.  Specifically,  two 3D acquisitions  of 
each lesion  would  be obtained  after contrast  has been  injected.  These  will be acquired  with the RSP6 -16-D 
mechanical  3D probe.  One acquisition  would  be done  with the vessel  longitudinally  oriented  in the acquired  
image  plane,  and the other  would  orient  the vessel  trans -axially.  
 
Endarterectomy Sample Analysis:  If the surgeon sends the endarterectomy sample for pathological 
examination, we will analyze slides in the Tissue Registry. If the endarterec tomy sample is not sent for 
pathological examination, fresh tissue from endarterectomy would be collected during the patient’s surgery. If 
possible, the whole atherosclerotic plaque would be collected, but half the available specimen would also be 
suitable . The sample will be fixed in 10% neutral buffered formalin and subsequently embedded in paraffin 
(FFPE).  Slides will be processed identically, whether processed clinically or for the purposes of research. 
Several slides (up to 6) with various stains will be processed for each block. These stains include hematoxylin 
and eosin (H & E), Verhoeff -van Gieson (VVG), Masson’s trichrome, and CD31 antibody. The slides will be 5 
microns thick for each stain. Slides will be stored in Dr. Urban’s laboratory. Dr.  (a 
cardiovascular pathologist) will review the slides for this study.  
 

 
  Page 7 of 13 
  
 
 
 
 
 
 
 
 
 
 
  Page 10 of 13 
 [1] D. Mozaffarian, E. J. Benjamin, A. S. Go, D. K. Arnett, M. J. Blaha, M. Cushman, S. de Ferranti, J. -P. 
Després, H. J . Fullerton, V. J. Howard, M. D. Huffman, S. E. Judd, B. M. Kissela, D. T. Lackland, J. H. 
Lichtman, L. D. Lisabeth, S. Liu, R. H. Mackey, D. B. Matchar, D. K. McGuire, E. R. Mohler, C. S. 
Moy, P. Muntner, M. E. Mussolino, K. Nasir, R. W. Neumar, G. Nichol , L. Palaniappan, D. K. Pandey, 
M. J. Reeves, C. J. Rodriguez, P. D. Sorlie, J. Stein, A. Towfighi, T. N. Turan, S. S. Virani, J. Z. Willey, 
D. Woo, R. W. Yeh, and M. B. Turner, "Heart disease and stroke statistics —2015 update: A report from 
the American H eart Association," Circulation, vol. 131, pp. e29 -e322, January 27, 2015 2015.  
[2] J. R. Crouse, "Imaging atherosclerosis: state of the art," J. Lipid Res., vol. 47, pp. 1677 -1699, August 1, 
2006 2006.  
[3] B. M. W. de Vries, G. M. van Dam, R. A. Tio, J. -L. Hillebrands, R. H. J. A. Slart, and C. J. Zeebregts, 
"Current imaging modalities to visualize vulnerability within the atherosclerotic carotid plaque," J. Vasc. 
Surg., vol. 48, pp. 1620 -1629, 2008.  
[4] G. L. ten Kate, E. J. Sijbrands, D. Staub, B. Coll, F . J. ten Cate, S. B. Feinstein, and A. F. L. Schinkel, 
"Noninvasive imaging of the vulnerable atherosclerotic plaque," Curr. Prob. Cardiol., vol. 35, pp. 556 -
591, 2010.  
[5] T. Noguchi, N. Yamada, T. Kawasaki, A. Tanaka, and S. Yasuda, "Detection of high -risk atherosclerotic 
plaques by magnetic resonance imaging," Circ. J., vol. 77, pp. 1975 -1983, 2013.  
[6] J. M. Cai, T. S. Hatsukami, M. S. Ferguson, W. S. Kerwin, T. Saam, B. C. Chu, N. Takaya, N. L. 
Polissar, and C. Yuan, "In vivo quantitative measurement o f intact fibrous cap and lipid -rich necrotic 
core size in atherosclerotic carotid plaque - Comparison of high -resolution, contrast -enhanced magnetic 
resonance imaging and histology," Circulation, vol. 112, pp. 3437 -3444, Nov 2005.  
[7] H. R. Underhill, T. S . Hatsukami, J. Cai, W. Yu, J. K. DeMarco, N. L. Polissar, H. Ota, X. Zhao, L. 
Dong, M. Oikawa, and C. Yuan, "A noninvasive imaging approach to assess plaque severity: The 
Carotid Atherosclerosis Score," Am J Neuroradiol, vol. 31, pp. 1068 -1075, June 1, 20 10 2010.  
[8] W. Brinjikji, J. Huston, A. A. Rabinstein, G. -M. Kim, A. Lerman, and G. Lanzino, "Contemporary 
carotid imaging: from degree of stenosis to plaque vulnerability," J Neurosurg, vol. 124, pp. 27 -42, 
2016/01/01 2015.  
[9] A. G. den Hartog, S. M. Bo vens, W. Koning, J. Hendrikse, P. R. Luijten, F. L. Moll, G. Pasterkamp, and 
G. J. de Borst, "Current status of clinical magnetic resonance imaging for plaque characterisation in 
patients with carotid artery stenosis," Eur. J. Vasc. Endovasc. Surg., vol. 4 5, pp. 7 -21, 2013.  
[10] T. Saam, T. S. Hatsukami, N. Takaya, B. C. Chu, H. Underhill, W. S. Kerwin, J. M. Cai, M. S. 
Ferguson, and C. Yuan, "The vulnerable, or high -risk, atherosclerotic plaque: Noninvasive MR imaging 
for characterization and assessment," Radiology, vol. 244, pp. 64 -77, Jul 2007.  
[11] J. K. DeMarco and J. Huston, "Imaging of high -risk carotid artery plaques: current status and future 
directions," Neurosurgical Focus, vol. 36, p. E1, 2014/01/01 2014.  
[12] M. M. Mughal, M. K. Khan, J. K. DeMa rco, A. Majid, F. Shamoun, and G. S. Abela, "Symptomatic and 
asymptomatic carotid artery plaque," Expert Review of Cardiovascular Therapy, vol. 9, pp. 1315 -1330, 
2011/10/01 2011.  
[13] J. Narula, M. Nakano, R. Virmani, F. D. Kolodgie, R. Petersen, R. Newcom b, S. Malik, V. Fuster, and 
A. V. Finn, "Histopathologic characteristics of atherosclerotic coronary disease and implications of the 
findings for the invasive and noninvasive detection of vulnerable plaques," J. Am. Coll. Cardiol., vol. 
61, pp. 1041 -1051, 2013.  
[14] M. Naghavi, P. Libby, E. Falk, S. W. Casscells, S. Litovsky, J. Rumberger, J. J. Badimon, C. Stefanadis, 
P. Moreno, G. Pasterkamp, Z. Fayad, P. H. Stone, S. Waxman, P. Raggi, M. Madjid, A. Zarrabi, A. 
Burke, C. Yuan, P. J. Fitzgerald, D. S. Sisc ovick, C. L. de Korte, M. Aikawa, K. E. J. Airaksinen, G. 
 
  Page 11 of 13 
 Assmann, C. R. Becker, J. H. Chesebro, A. Farb, Z. S. Galis, C. Jackson, I. K. Jang, W. Koenig, R. A. 
Lodder, K. March, J. Demirovic, M. Navab, S. G. Priori, M. D. Rekhter, R. Bahr, S. M. Grundy, R.  
Mehran, A. Colombo, E. Boerwinkle, C. Ballantyne, W. Insull, R. S. Schwartz, R. Vogel, P. W. Serruys, 
G. K. Hansson, D. P. Faxon, S. Kaul, H. Drexler, P. Greenland, J. E. Muller, R. Virmani, P. M. Ridker, 
D. P. Zipes, P. K. Shah, and J. T. Willerson, "Fro m vulnerable plaque to vulnerable patient - A call for 
new definitions and risk assessment strategies: Part II," Circulation, vol. 108, pp. 1772 -1778, Oct 2003.  
[15] A. A. Alsheikh -Ali, G. D. Kitsios, E. M. Balk, J. Lau, and S. Ip, "The vulnerable atherosc lerotic plaque: 
scope of the literature," Ann. Intern. Med., vol. 153, pp. 387 -395, 2010.  
[16] J. F. Bentzon, F. Otsuka, R. Virmani, and E. Falk, "Mechanisms of plaque formation and rupture," 
Circ.Res., vol. 114, pp. 1852 -1866, Jun 2014.  
[17] M. G. Henneri ci, "The unstable plaque," Cerebrovasc. Dis., vol. 17(suppl 3), pp. 17 -22, 2004.  
[18] J. P. Carpenter, F. J. Lexa, and J. T. Davis, "Determination of Duplex Doppler Ultrasound Criteria 
Appropriate to the North American Symptomatic Carotid Endarterectomy Tr ial," vol. 27, pp. 695 -699, 
April 1, 1996 1996.  
[19] C. Schmitt, G. Soulez, R. L. Maurice, M. -F. Giroux, and G. Cloutier, "Noninvasive Vascular 
Elastography: Toward A Complementary Characterization Tool of Atherosclerosis in Carotid Arteries," 
Ultrasound M ed Biol, vol. 33, pp. 1841 -1858, 2007.  
[20] C. L. de Korte, E. I. Cespedes, A. F. W. van der Steen, G. Pasterkamp, and N. Bom, "Intravascular 
ultrasound elastography: assessment and imaging of elastic properties of diseased arteries and vulnerable 
plaque,"  Eur. J. Ultrasound, vol. 7, pp. 219 -224, 1998.  
[21] J. A. Schaar, C. L. de Korte, F. Mastik, R. Baldewsing, E. Regar, P. de Feyter, C. J. Slager, A. F. van der 
Steen, and P. W. Serruys, "Intravascular palpography for high -risk vulnerable plaque assessment ," Herz, 
vol. 28, pp. 488 -95, Sep 2003.  
[22] J. A. Schaar, C. L. de Korte, F. Mastik, L. C. van Damme, R. Krams, P. W. Serruys, and A. F. van der 
Steen, "Three -dimensional palpography of human coronary arteries. Ex vivo validation and in -patient 
evaluation ," Herz, vol. 30, pp. 125 -33, Mar 2005.  
[23] Y. Majdouline, J. Ohayon, Z. Keshavarz -Motamed, M. -H. Roy Cardinal, D. Garcia, L. Allard, S. 
Lerouge, F. Arsenault, G. Soulez, and G. Cloutier, "Endovascular shear strain elastography for the 
detection and chara cterization of the severity of atherosclerotic plaques: in  vitro validation and in  vivo 
evaluation," Ultrasound Med Biol, vol. 40, pp. 890 -903, 2014.  
[24] R. A. Baldewsing, J. A. Schaar, F. Mastik, C. W. J. Oomens, and A. F. W. van der Steen, "Assessment 
of vulnerable plaque composition by matching the deformation of a parametric plaque model to 
measured plaque deformation," IEEE Trans Med Imaging, vol. 24, pp. 514 -528, 2005.  
[25] J. J. Dahl, D. M. Dumont, J. D. Allen, E. M. Miller, and G. E. Trahey, "Acous tic radiation force impulse 
imaging for noninvasive characterization of carotid artery atherosclerotic plaques: a feasibility study," 
Ultrasound Med. Biol., vol. 35, pp. 707 -716, May 2009.  
[26] D. Dumont, R. H. Behler, T. C. Nichols, E. P. Merriciks, and C . M. Gallippi, "ARFI imaging for 
noninvasive material characterization of atherosclerosis," Ultrasound Med. Biol., vol. 32, pp. 1703 -
1711, Nov 2006.  
[27] R. H. Behler, T. C. Nichols, E. R. Merricks, and C. M. Gallippi, "ARFI ultrasound for enhanced 
delinea tion of atherosclerosis in women," J. Womens Health, vol. 16, pp. 1112 -1113, Oct 2007.  
[28] R. Behler, T. Nichols, E. Merricks, and C. Gallippi, "ARFI ultrasound for discrimination of calcification 
in arterial plaques: additional progress toward improved a therosclerosis imaging in women," J. Womens 
Health, vol. 17, pp. 1243 -1243, Oct 2008.  
 
  Page 12 of 13 
 [29] R. H. Behler, T. C. Nichols, H. T. Zhu, E. P. Merricks, and C. M. Gallippi, "ARFI imaging for 
noninvasive material characterization of atherosclerosis part II: towar d in vivo characterization," 
Ultrasound Med. Biol., vol. 35, pp. 278 -295, Feb 2009.  
[30] J. D. Allen, K. L. Ham, D. M. Dumont, B. Sileshi, G. E. Trahey, and J. J. Dahl, "The development and 
potential of acoustic radiation force impulse (ARFI) imaging for c arotid artery plaque characterization," 
Vasc. Med., vol. 16, pp. 302 -311, Aug 2011.  
[31] J. R. Doherty, D. M. Dumont, G. E. Trahey, and M. L. Palmeri, "Acoustic radiation force impulse 
imaging of vulnerable plaques: a finite element method parametric analy sis," J. Biomech., vol. 46, pp. 
83-90, 2013.  
[32] V. Patel, J. J. Dahl, D. P. Bradway, J. R. Doherty, S. Y. Lee, and S. W. Smith, "Acoustic Radiation 
Force Impulse Imaging (ARFI) on an IVUS Circular Array," Ultrason Imaging, vol. 36, pp. 98 -111, 
April 1, 2 014 2014.  
[33] J. R. Doherty, J. J. Dahl, and G. E. Trahey, "Harmonic Tracking of Acoustic Radiation Force -Induced 
Displacements," IEEE Trans. Ultrason. Ferroelectr. Freq. Control, vol. 60, pp. 2347 -2358, Nov 2013.  
[34] K. V. Ramnarine, J. W. Garrard, K. D exter, S. Nduwayo, R. B. Panerai, and T. G. Robinson, "Shear 
wave elastography assessment of carotid plaque stiffness: in  vitro reproducibility study," Ultrasound 
Med Biol, vol. 40, pp. 200 -209, 2014.  
[35] K. V. Ramnarine, J. W. Garrard, B. Kanber, S. Nduw ayo, T. C. Hartshorne, and T. G. Robinson, "Shear 
wave elastography imaging of carotid plaques: feasible, reproducible and of clinical potential," 
Cardiovasc. Ultrasound, vol. 12, Dec 2014.  
[36] P. Song, H. Zhao, A. Manduca, M. W. Urban, J. F. Greenleaf, a nd S. Chen, "Comb -push ultrasound 
shear elastography (CUSE): a novel method for two -dimensional shear elasticity imaging of soft 
tissues," IEEE Trans. Med. Imaging, vol. 31, pp. 1821 -1832, 2012.  
[37] P. Song, A. Manduca, H. Zhao, M. W. Urban, J. F. Greenle af, and S. Chen, "Fast shear compounding 
using robust 2 -D shear wave speed calculation and multi -directional filtering," Ultrasound Med. Biol., 
vol. 40, pp. 1343 -1355, 2014.  
[38] E. Widman, E. Maksuti, D. Larrsson, M. W. Urban, A. Bjällmark, and M. Larsson , "Shear wave 
elastography plaque characterization with mechanical testing validation – a phantom study," Phys. Med. 
Biol., vol. 60, pp. 3151 -3174, 2015.  
[39] J. Nakamura, T. Nakamura, J. Deyama, D. Fujioka, K. Kawabata, J. Obata, K. Watanabe, Y. Watanabe,  
and K. Kugiyama, "Assessment of carotid plaque neovascularization using quantitative analysis of 
contrast -enhanced ultrasound imaging is useful for risk stratification in patients with coronary artery 
disease," Int. J. Cardiol., vol. 195, pp. 113 -119, Sep  2015.  
[40] J. Deyama, T. Nakamura, I. Takishima, D. Fujioka, K. -i. Kawabata, J. -e. Obata, K. Watanabe, Y. 
Watanabe, Y. Saito, H. Mishina, and K. Kugiyama, "Contrast -Enhanced Ultrasound Imaging of Carotid 
Plaque Neovascularization Is Useful for Identifying  High -Risk Patients With Coronary Artery Disease," 
Circulation Journal, vol. 77, pp. 1499 -1507, 2013.  
[41] F. Shah, P. Balan, M. Weinberg, V. Reddy, R. Neems, M. Feinstein, J. Dainauskas, P. Meyer, M. 
Goldin, and S. B. Feinstein, "Contrast -enhanced ultraso und imaging of atherosclerotic carotid plaque 
neovascularization: a new surrogate marker of atherosclerosis?," Vasc Med, vol. 12, pp. 291 -297, 
November 1, 2007 2007.  
[42] R. Huang, S. S. Abdelmoneim, C. A. Ball, L. F. Nhola, A. M. Farrell, S. Feinstein, an d S. L. Mulvagh, 
"Detection of carotid atherosclerotic plaque neovascularization using contrast enhanced ultrasound: a 
systematic review and meta -analysis of diagnostic accuracy studies," J. Am. Soc. Echocardiography, 
2016, In press.  
 
  Page 13 of 13 
 [43] O. Honda, S. Sugi yama, K. Kugiyama, H. Fukushima, S. Nakamura, S. Koide, S. Kojima, N. Hirai, H. 
Kawano, H. Soejima, T. Sakamoto, M. Yoshimura, and H. Ogawa, "Echolucent carotid plaques predict 
future coronary events in patients with coronary artery disease," J Am Coll Car diol, vol. 43, pp. 1177 -
1184, 2004.  
[44] S. Sabeti, O. Schlager, M. Exner, W. Mlekusch, J. Amighi, P. Dick, G. Maurer, K. Huber, R. 
Koppensteiner, O. Wagner, E. Minar, and M. Schillinger, "Progression of carotid stenosis detected by 
duplex ultrasonography predicts adverse outcomes in cardiovascular high -risk patients," Stroke, vol. 38, 
p. 2887, 2007.  
 